Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Approaching Scarless Wound Healing: From Passive Anti-Fibrotic to Proactive and Programmable Pro-Regenerative Strategies

Fu M., Huang Z., Li J., Li Y., Fang Z., Jiang Y.

Narrative Review on Chronic Wound, Scar, published in Adv Sci (Weinh) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Sci (Weinh) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41732917
PMCID
PMC13042657
DOI
10.1002/advs.202521824

Abstract (original English)

Pathological scarring after skin wound healing poses a substantial clinical difficulty, essentially representing a fibrotic outcome of dysregulated tissue repair. This review provides a comprehensive analysis of the physiological processes of wound healing and key factors in scar formation, focusing on the unique mechanisms of scarless regeneration models such as early-stage fetuses and spiny mouse (Acomys cahirinus). These models rely heavily on the immune microenvironment's regulation, the dynamic remodeling of the extracellular matrix (ECM), and precise cell behavior regulation to achieve perfect regeneration. Building upon this foundation, this review delves into emerging scar prevention methods from the perspective of tissue engineering materials. These encompass multi-dimensional interventions, including the construction of biomimetic microenvironments, regulation of key cell fates, sequential multi-target intervention in pathological processes, and the integration of smart materials with advanced manufacturing technologies. Through interdisciplinary integration and innovation, shifting scar prevention and treatment strategies from passive anti-fibrosis to proactive promoting regeneration, guiding wounds toward true structural and functional regeneration, emerges as a promising path to overcome current limitations in scar management.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CicatrixExtracellular MatrixSkinAnimalsHumansFibrosisTissue EngineeringRegenerationWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research